Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BTD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SACS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC7A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928940 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMBRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHBDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARNTL2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTXN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBED6CL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMPCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC19A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTNAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on